A new personalized vaccine has been tried out. It is built from a patient's immune cells and tumour cells. In the study the approach has been tried with 25 patients with an advanced form of ovarian cancer; in half of the patients, there was after the vaccination a big increase of T-cells and all those patients survived for a 2-year period compared to only 25% for the others.
Contact: info(@)neat-news(dot)com.
neat-news.com is not responsible for the content of external sites.
We do not link to external sites in return for money or any other benefits.
Note that photos are usually stock photos, mostly taken from
Wikipedia, which we can use royalty-free either since they are in
the public domain or available under an open licence such as
a share alike licence.
The page is maintained in Germany and for any legal matters the
laws of Germany apply.
Any warranty or liability is excluded in the widest legally
possible sense.
© neat-news.com 2016-2025.